Carboplatin, Durvalumab, Gemcitabine, and Tremelimumab
About
Membership operator: AND
Therapies: 4
Therapies
Carboplatin (tx:ncit:C1282)
Durvalumab (tx:ncit:C103194)
Gemcitabine (tx:ncit:C66876)
Tremelimumab (tx:ncit:C49085)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (4) | Wild type ALK, Wild type EGFR | Non-Small Cell Lung Cancer | Carboplatin, Durvalumab, Gemcitabine, Tremelimumab |